Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies

Transplant International

Volumn 13, Issue SUPPL. 1, 2000, Pages

  Wagenknecht, D R ^a   Fastenau, D R ^a   Torry, R J ^a,b   Becker, D G ^c   LeFor, W M ^c   Carter, C B ^a   Haag, B W ^a   McIntyre, J A ^a  

^a METHODIST HOSPITAL   (United States)

^b DRAKE UNIVERSITY   (United States)

^c LifeLink Foundation   (United States)

Author keywords

Anticardiolipin antibodies; Antiphosphatidylethanolamine antibodies; Antiphosphatidylserine antibodies; Rejection; Thrombosis

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; PHYSIOLOGY; POSTOPERATIVE PERIOD; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTIBODIES, ANTIPHOSPHOLIPID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KIDNEY TRANSPLANTATION; POSTOPERATIVE PERIOD; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0001805467     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb02122.x     Document Type: Article

References (18)

1. Colman RW, Braun WE, Busch G, Dammin GJ, Merrill JP (1969) Coagulation studies in the hyperacute and other forms of renal allograft rejection. N Engl J Med 281: 685-691
2. Del Papa N, Sheng YH, Raschi E, Kandiah DA, Tincani A, Khamashta MA, Atsumi T, Hughes GR, Ichikawa K, Koike T, Balestrieri G, Krillis SA, Meroni PL (1998) Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies. J Immunol 160: 5572-5578
3. Ducloux D, Pellet E, Fournier V, Rebibou JM, Bresson-Vautrin C, Rracadot E, Fellmann D, Chalopin JM (1999) Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. Transplantation 67: 90-93
4. Heerde WL van, deGroot PG, Reutelingsperger CPM (1995) The complexity of the phospholipid binding protein annexin V. Thromb Haemost 73: 172-179
5. Humar A, Johnson EM, Gillingham KJ, Sutherland DE, Payne WD, Dunn DL, Wrenshall LE, Najarian JS, Gruessner RW, Matas AJ (1998) Venous thromboembolic complications after kidney and kidney-pancreas transplantation. Transplantation 65: 229-234
6. Oosting JD, Derksen RHWM, Bobbink IWG, Hackeng TM, Bouma BN, deGroot PG (1993) Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanisms? Blood 81: 2618-2625
7. Rodriguez-Erdmann F, Guttmann RD (969) Coagulation in renal-allograft rejection. N Engl J Med 281: 1428
8. 2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66: 1086-1091
9. Singh A, Stablein D, Tejani A (1997) Risk factors for vascular thrombosis in pediatric renal transplantation. Transplantation 63: 1263-1267
10. Starzl TE, Boehmig HJ, Amemiya H, Wilson CB, Dixon FJ, Giles GR, Simpson KM, Halgrimson CG (1970) Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med 283: 283-390
11. Sugi T, McIntyre JA (1995) Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 86: 3083-3089
12. Sugi T, McIntyre JA (1995) Plasma proteins required for antiphospholipid antibody detection. Nouv Rev Fr Hematol 37:S49-S52
13. Sugi T, McIntyre JA (1996) Autoantibodies to kininogen-phosphatidylethanolamine complexes augment thrombin-induced platelet aggregation. Thromb Res 84: 97-109
14. Triplett DA (1995) Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res 78: 1-31
15. 2-glycoprotein I and antiphospholipid antibodies in vitro. Thromb Res 68: 495-500
16. Wagenknecht DR, McIntyre JA (1994) Prothrombin: a factor in the antiphospholipid antibody (aPA) ELISA. Lupus 3: 364
17. Wagenknecht DR, Becker DG, LeFor WM, McIntyre JA (1999) Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation 68 (in press)
18. Wagenknecht DR, Fastenau DR, Torry RJ, Carter CB, Haag BW, McIntyre JA (1999) Antiphospholipid antibodies are a risk factor for early renal allograft failure: isolation of antiphospholipid antibodies from a thrombosed renal allograft. Transplant Proc 31: 285-288